Search
for
Sort by
Research 31–60 of 60
- Bladder Cancer Survival of Men Receiving 5α-Reductase Inhibitors
- Steroid 5α-reductase 2 deficiency leads to reduced dominance-related and impulse-control behaviors
- Exploring the neural mechanisms of finasteride: a proteomic analysis in the nucleus accumbens
- Trends in the Development of New Drugs for Treatment of Benign Prostatic Hyperplasia
- Dihydrotestosterone Induces Proliferation, Migration, and Invasion of Human Glioblastoma Cell Lines
- Recent Advances in Drug Design and Drug Discovery for Androgen- Dependent Diseases
- Repurposing steroidogenesis inhibitors for the therapy of neuropsychiatric disorders: Promises and caveats
- Co-administration of 5α-reductase Inhibitors Worsens the Adverse Metabolic Effects of Prescribed Glucocorticoids
- Circulating and intraprostatic sex steroid hormonal profiles in relation to male pattern baldness and chest hair density among men diagnosed with localized prostate cancers
- Bladder cancer survival in men using 5-alpha-reductase inhibitors
- The 5α-reductase inhibitor finasteride is not associated with alterations in sleep spindles in men referred for polysomnography
- RE: EFFECT OF THE DUAL 5α-REDUCTASE INHIBITOR DUTASTERIDE ON MARKERS OF TUMOR REGRESSION IN PROSTATE CANCER
- Farmácia São Lázaro - Porto e nos Serviços Farmacêuticos do Hospital Privado de Vila Real (Grupo Trofa Saúde) - Vila Real
- Exploring the Potential of Eclipta alba: A Promising Approach for Hair Treatment Management through 5-Alpha Reductase Inhibition
- Encapsulación en ciclodextrinas de compuestos con actividad frente a la alopecia androgénica masculina.
- The role of hair follicles and Edar signalling in cutaneous wound healing
- Unravelling the link between insulin resistance and androgen excess
- Effects of 5-alpha reductase inhibitors on erectile function, sexual desire and ejaculation
- The effects of finasteride on scalp skin and serum androgen levels in men with androgenetic alopecia
- Incomplete Recovery of Erectile Function in Rat after Discontinuation of Dual 5‐Alpha Reductase Inhibitor Therapy
- Evaluation of bioequivalence of five 0.1 mg dutasteride capsules compared to one 0.5 mg dutasteride capsule: a randomized study in healthy male volunteers
- Synthesis and 5α-Reductase Inhibitory Activity of C21 Steroids Having 1,4-diene or 4,6-diene 20-ones and 4-Azasteroid 20-Oximes
- Pathogenesis of androgenetic alopecia
- Prolactin as a candidate sebotrop(h)ic hormone?
- 5α-reductase inhibitors impact prognosis of urothelial carcinoma
- Early embryonic exposure of freshwater gastropods to pharmaceutical 5-alpha-reductase inhibitors results in a surprising open-coiled “banana-shaped” shell
- Antioxidant and 5α-Reductase Inhibitory Activity of Momordica charantia Extract, and Development and Characterization of Microemulsion
- Investigation of Transcriptional Gene Profiling in Normal Murine Hair Follicular Substructures Using Next-Generation Sequencing to Provide Potential Insights into Skin Disease
- Th,-e mechanistic insights into the application of retinoids and possible adjunct therapeutic treatment to androgenic alopecia
- Role of Polyphenols in Dermatological Diseases: Exploring Pharmacotherapeutic Mechanisms and Clinical Implications